Is it a good company at a reasonable price? This stock tends to be cyclical and it is just off it most recent high point. Analyst expect the next two years to be good, but EPS and ASEP is expected to drop by almost 20% in 2027 from that of 2026. A number of tests say that the stock price is reasonable, but the Dividend Yield tests do not. I would go with the Dividend yield tests.
I do not own this stock of Methanex Corp (TSX-MX, NASDAQ-MEOH). I started a spreadsheet in November 2010 as I had read some good reports on the stock at that time. It is also got a solid “C” grade in a 2009 Money Sense review of stocks. Money Sense rated the top 100 Canadian Dividend Paying stocks. Money Sense was looking for stocks that provided generous income at reasonable prices. This stock is not always on the Money Sense list but it is on the list for 2026.
When I was updating my spreadsheet, I noticed that the stock price has climbed some 84% so far this year. Revenue is up 18% in the third quarter of 2026 with EPS up 387% and Adjusted EPS up 303%. They are having a very good year. This stock reports in US$ and dividends are paid in US$.
If you look at the Total Return per Year is shown below for years of 5 to 30 to the end of November 13, 2026 in CDN$ and the one for Total Return per Year is shown below for years of 5 to 30 to the end of 2025 in CDN$. They are very different. Capital gain for the past 5 years to November 13, 2026 is 12.75% compared to Capital gain for the past 5 years to the end of 2025 of a negative 1.42.%
Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|---|
| 2020 | 5 | 20.68% | 14.31% | 12.75% | 1.56% |
| 2015 | 10 | -3.31% | 6.09% | 4.47% | 1.62% |
| 2010 | 15 | 3.01% | 12.39% | 9.52% | 2.87% |
| 2005 | 20 | 3.17% | 7.31% | 5.39% | 1.92% |
| 2000 | 25 | 5.87% | 13.21% | 9.79% | 3.42% |
| 1995 | 30 | 8.64% | 6.86% | 1.78% |
If you had invested in this company in December 2015, for $1,005.40 you would have bought 22 shares at $45.70 per share. In December 2025, after 10 years you would have received $252.58 in dividends. The stock would be worth $1,197.68. Your total return would have been $1,450.26. This would be a total return of 4.16% per year with 1.77% from capital gain and 2.39% from dividends.
| Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
|---|---|---|---|---|---|---|
| $45.70 | $1,005.40 | 22 | 10 | $252.58 | $1,197.68 | $1,450.26 |
In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth expected over 12 months to the Third quarter in 2026 and expected growth over this year. I am now including EBITDA in this chart as this item is becoming more important for analyzing stocks.
The last row of the stock price growth is for the next 12 months. This chart is in US$ as this company reports in US$
| Yr | Item | Tot. Gwth | Per Year | Gwth | Coverage |
|---|---|---|---|---|---|
| 5 | Revenue Growth | 35.44% | 6.26% | 31.65% | <-12 mths |
| 5 | AEPS Growth | 225.31% | 26.61% | 123.15% | <-12 mths |
| 5 | Net Income Growth | 150.98% | 20.21% | 351.25% | <-12 mths |
| 5 | EBITDA Growth | 133.53% | 18.49% | 88.86% | <-12 mths |
| 5 | Cash Flow Growth | 120.26% | 17.11% | 43.46% | <-12 mths |
| 5 | Dividend Growth | 56.61% | 9.39% | 0.00% | <-12 mths |
| 5 | Stock Price Growth | -13.80% | -2.93% | 77.52% | <-12 mths |
| 10 | Revenue Growth | 61.27% | 4.90% | 45.52% | <-this year |
| 10 | AEPS Growth | 69.17% | 5.40% | 70.94% | <-this year |
| 10 | Net Income Growth | -60.18% | -8.80% | 1319.15% | <-this year |
| 10 | EBITDA Growth | 101.50% | 7.26% | 138.61% | <-this year |
| 10 | Cash Flow Growth | 242.00% | 13.08% | 64.24% | <-this year |
| 10 | Dividend Growth | -31.16% | -3.67% | 43.26% | <-this year |
| 10 | Stock Price Growth | 20.33% | 1.87% | 21.74% | <-12 mths |
The current dividend yield is low with dividend growth has been suspended. The dividend yield is low (below 2%) at 1.11%. The 5 and 10 year median dividend yields are also low at 1.59% and 1.76%. The historical median dividend yield is moderate (2% to 4% ranges) at 2.20%. Dividend growth is moderate (between 8% and 14% ranges per year) at 9.4% per year over the past 5 years. The last dividend increase was in 2023 and it was for 5.7%.
The Dividend Payout Ratios (DPR) are good. The DPR for 2025 for Earnings per Share (EPS) is high at 58% with 5 year coverage good at 19%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 36% with 5 year coverage at 21%. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 7% with 5 year coverage at 5%. The DPR for 2025 for Free Cash Flow (FCF) is good at 9% with 5 year coverage at 16%.
| Item | Cur | 5 Years |
|---|---|---|
| EPS | 58.05% | 18.72% |
| AEPS | 36.45% | 21.42% |
| CFPS | 7.06% | 4.99% |
| FCF | 8.72% | 15.74% |
Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.88 and currently at 0.40. The Liquidity Ratio for 2025 is good at 2.06 and 1.69 currently. The Debt Ratio for 2025 is good at 1.60 and 1.70 currently. The Leverage and Debt/Equity Ratios for 2025 are fine at 2.98 and 1.86 and currently at 2.70 and 1.59.
| Type | Year End | Ratio Curr |
|---|---|---|
| Lg Term R | 0.88 | 0.40 |
| Intang/GW | 0.00 | 0.00 |
| Liquidity | 2.06 | 1.69 |
| Liq. + CF | 3.39 | 2.98 |
| Debt Ratio | 1.60 | 1.70 |
| Leverage | 2.98 | 2.70 |
| D/E Ratio | 1.86 | 1.59 |
The Total Return per Year is shown below for years of 5 to 30 to the end of 2025 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|---|
| 2020 | 5 | 11.01% | 0.09% | -1.42% | 1.51% |
| 2015 | 10 | -3.76% | 4.16% | 1.77% | 2.39% |
| 2010 | 15 | 3.37% | 6.81% | 4.00% | 2.81% |
| 2005 | 20 | 3.83% | 7.53% | 4.67% | 2.86% |
| 2000 | 25 | 8.42% | 10.66% | 7.17% | 3.50% |
| 1995 | 30 | 8.12% | 5.81% | 2.31% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are 14.43, 17.85 and 21.26. The corresponding 10 year ratios are 9.20, 11.61 and 14.03. The corresponding historical ratios are 9.55, 10.79 and 15.19. The current ratio is 5.87 based on a stock price of $91.20 and EPS estimate for 2026 of $15.54 ($10.90 US$). The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap. This testing is in CDN$. (Note that analysts seem to expect a big jump in EPS for 2026 with EPS going from $0.93 to $10.90. EPS for the last 12 months to the end of the third quarter supports this idea.)
I also have Adjusted Earning per Share (AEPS) data. The 5-year low, median, and high median Price/Earnings per Share Ratios are 9.83, 12.31 and 14.80. The corresponding 10 year ratios are 9.18, 11.50 and 13.83. The corresponding historical ratios are 13.17, 10.16 and 13.17. The current ratio is 6.16 based on a stock price of $63.80 and AEPS estimate for 2026 of $10.35. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap. This testing is in US$. (Note that analysts seem to expect a big jump in AEPS for 2026 with AEPS going from $2.03 to $10.35. AEPS for the last 12 months to the end of the third quarter supports this idea.)
I get a Graham Price of $134.49. The 10-year low, median, and high median Price/Graham Price Ratios are 0.84, 1.08 and 1.31. The current ratio is 0.68 based on a stock price of $91.20. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap. This testing is in CDN$.
I get a 10-year median Price/Book Value per Share Ratio of 1.85. Th current P/B Ratio is 1.76 based on Book Value of $3,105M, Book Value per Share of $36.30 and a stock price of $63.80. The current ratio is 5% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in US$.
I also have Book Value per Share estimates for 2026 of $39.85. This implies a ratio of 1.60 based on a stock price of $63.80. This ratio is 13% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median. This testing is in US$.
I get a 10-year median Price/Cash Flow per Share Ratio of 4.68. The current ratio is 2.96 based on Cash Flow per Share estimate for 2026 of $21.56, Cash Flow of $1,668M and a stock price of $63.80. The current ratio is 37% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap. This testing is in US$.
I get an historical median dividend yield of 2.20%. The current dividend yield is 1.16% based on dividends of $0.74 and a stock price of $63.80. The current dividend yield is 47% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
I get a 10 year median dividend yield of 1.76%. The current dividend yield is 1.16% based on dividends of $0.74 and a stock price of $63.80. The current dividend yield is 34% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively expensive. This testing is in US$.
The 10-year median Price/Sales (Revenue) Ratio is 0.84. The current P/S Ratio is $0.95 based on a stock price of $63.80, Revenue estimate for 2026 of $5,223M and Revenue per Share of $67.51. The current ratio is 12% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. Revenue is expected to rise in 2026 by some 46%, but AEPS is expected to rise some 410%.
Results of stock price testing is that the stock price maybe reasonable, but maybe not. The dividends have not increased in the past few years, so you have to wonder about the increase in earnings just being a temporary thing. This stock tends to be cyclical and it is off its recent high. The dividend yield tests say it is relatively expensive, but the P/S Ratio test says it is reasonable but above the median. However, a number of tests say it is relatively cheap. This is true of the P/S Ratio and Price/Graham Price Ratio tests.
When I look at analysts’ recommendations, I find Strong Buy (5), Buy (2) and Hold (3). The consensus is a Strong Buy. The 12 month target price is $111.03 with a high of $118.79 and low of $88.05. The 12 month stock price of $111.03 implies a total return of $22.90% with 21.74% from capital gains and 1.16% from dividends based on a current stock price of $91.20.
There are three entries on Stock Chase for 2026 and the last two entries said they just sold this stock. Jitendra Parashar on Motley Fool says under What to Watch for November 2 list this stock saying it jumped nearly 14% after a strong third-quarter. There are no other entries on Motley Fool for 2026 for this stock. The company put out a Press Release about their fourth quarter results for 2025. The company put out a Press Release about their third quarter results for 2026.
Zack via Yahoo Finance reviews this stock and asks if Methanex is outpacing its Basic Materials Peers this year. Simply Wall Street via Motley Fool reviews this stock but says the risk of multi-year forecasts pointing to declining profits and revenue still exists.
Methanex Corp operates as a producer and supplier of methanol to various international markets in North America, Asia Pacific, Europe, and South America. The company's operations consist prominently of the production and sale of methanol, along with the production and sale of ammonia. Geographically, it operates in China, Europe, the United States, South America, South Korea, Other Asia, and Canada. The majority of revenue is derived from Europe. Its web site is here Methanex Corp.
The last stock I wrote about was about was Stantec Inc (TSX-STN, NYSE-STN) ... learn more. The next stock I will write about will be Magna International Inc (TSX-MG, NYSE-MGA) ... learn more on Friday, November 20, 2026 around 5 pm. Tomorrow on my other blog I will write about Frances Horodelski.... learn more on Thursday, November 19, 2026 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.